Safety Week and Automotive Testing Expo 2019
Last week CTS took part at the Safety Week and Automotive Testing Expo 2019 in Würzburg. Managing Director Peter Schimmelpfennig presented the latest generation of Biofidel dummies. The biofidelic dummy is the only dummy on the market which can both freely stand and sit. This and many other innovations of the latest dummy generation will also be on display this week at the Automotive Testing Expo Europe in Stuttgart. We would like to welcome you at the CTS booth which is located at booth number 1432. We are looking forward to seeing you there.
Dummies on a journey
Once again, biofidelic dummies from the CTS-dummy manufacture leave the crash facility. This time around though sitting rather than lying down. Usually the biofidelic dummies are shipped in specially designed transportation boxes. This week, however, one customer decided to personally collect the dummies and brought them securely strapped in to their new destination.
Schadenmanagement & Assistance 2019
Once again, CTS was represented at the trade fair congress Claims Management & Assistance in Leipzig with our partner company Accidenta. The focus was not only on the biofidelic dummy from our own dummy manufacturing facility, but also on the new crash test database, which CTS will publish in the coming months.
CTS starts off the seminar season
The new event hall is ready and the CTS team look forward to the seminar season starting in May. In 2019, there are many new aspects to the CTS-events sector, from exhibitors and exhibition areas to brand new seminars for learner drivers, car garages and rescue forces.
To start off with is the insurance seminar from our partner Accidenta on the 16th and 17th of May, followed by the 8th judicial seminar on the 28th of June 2019.
This year the experts seminar will take place from 05.-06.09.2019. Both this seminar and the insurance seminar will be accompanied for the first time by exhibitors from the service sector of accident reconstruction and damage claims adjusters.
In June and July the new series of seminars for learner drivers, car garages and rescue forces will celebrate its premiere.
We cordially invite you and look forward to welcoming you.
GPEC digital 2019
Analysis of pedestrian accidents
The Allianz Centre for Technology examines pedestrian accidents not only with a conventional view on the frequency and the avoidability, but also with a future-orientated view on the perceptibility of the sensibility of automated driving functions. For this, their own database of damages as well as numerous accident statistics have been combined, analysed information derived for the designing of assistance systems. New evaluations show that in particular senior citizens are at danger at low collision speeds. It is especially with this victim-group that developed restrictions in mobility and the high vulnerability a major role play in accidents. To visualise the problem, crash tests were carried out with a focus on older pedestrians with walking assistance (walking-frames). As a result of, not only the particular dramatic of such accidents with vehicles moving at even slow speeds at the point of collision are highlighted, but also the challenges of future vehicle sensors and automated driving systems. The results of the crash tests flow into work groups such as “AHEAD” (Aggregated Homologation-proposal for EventRecorderData for Automated Driving), who address clarification issues of accidents of automated vehicles with the aid of the recorded accident data from the vehicle. The biofidelic dummy offers, with its special and unique properties, crucial advantages for these tests in comparison to other pedestrian dummies.
A skeleton at AZT
As of this week, a skeleton of the biofidelic dummy is being displayed at the Allianz Centre for Technology in Munich. The AZT is the competence centre of the Allianz for Automotive Technology and has already previously carried out a series of crash tests with the biofidelic dummy. The skeleton serves here as an exhibition piece and should give visitors an insight into the complexity of the insides of the biofidelic dummy.